- Title
- Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
- Creators
- Jeremy M. Shefner - Barrow Neurological InstituteBjörn Oskarsson - Mayo Clinic in FloridaEric A. Macklin - Harvard UniversityLori B. Chibnik - Massachusetts General HospitalMelanie Quintana - Berry & Associates (United States)Benjamin R. Saville - Berry & Associates (United States)Michelle A. Detry - Berry & Associates (United States)Matteo Vestrucci - Berry & Associates (United States)Joe Marion - Berry & Associates (United States)Anna Mcglothlin - Berry & Associates (United States)et al.
- Publication Details
- JAMA : the journal of the American Medical Association, Vol.333(13), pp.1128-1137
- Number of pages
- 10
- Grant note
- Muscular Dystrophy Association (http://data.elsevier.com/vocabulary/SciValFunders/100005202) Prilenia Therapeutics CAMBR Charitable Foundation (http://data.elsevier.com/vocabulary/SciValFunders/100006430) ALS Finding a Cure ALS Association (http://data.elsevier.com/vocabulary/SciValFunders/100000971)
- Identifiers
- 991006262240302656
- Academic Unit
- Neurology
- Language
- English
- Resource Type
- Journal article
Journal article
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
JAMA : the journal of the American Medical Association, Vol.333(13), pp.1128-1137
04/01/2025
PMID: 40067755
Metrics
1 Record Views